| Authors: |
Delahunt B; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: brett.delahunt@otago.ac.nz., Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand., Christie D; Genesis Care, Tugun, Qld, Australia., Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia., Egevad L; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia., Kenwright DN; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand., Matthews J; Auckland City Hospital, Auckland, New Zealand., Murray JD; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand., Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia., Samaratunga H; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia., Spry NA; Genesis Care, Perth, WA, Australia., Thunders MC; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand., Hondermarck H; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia., Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia. |
